Table 1.
Baseline characteristics according to outcomes.
| Sample Characteristic | Survivors | Non-Survivors | p Value * |
|---|---|---|---|
| Sample Size (n) | 282 | 310 | - |
| Age, year | 56.8 (44.9–65.6) | 64.8 (55.8–72.3) | <0.001 |
| Sex (Male) | 132 (22.3) | 214 (36.1) | <0.001 |
| Status at Admission | |||
| Respiratory Rate, Breaths/min | 26 (22–32) | 25 (20–30) | 0.09 |
| Oxygen Saturation, % | 93 (90–95) | 93 (89–96) | 0.63 |
| Heart Rate, Beats/min | 90 (80–101) | 92 (80.3–101) | 0.4 |
| SAPS 3 | 61 (50–70.5) | 67 (54.5–77) | <0.001 |
| Blood Tests | |||
| Leucocytes, Thousand Per mm3 | 9.0 (6.9–12.4) | 8.8 (5.9–12.5) | 0.27 |
| Lymphocytes, thousand per mm3 | 0.9 (0.7–1.2) | 0.7 (0.5–1.1) | <0.001 |
| Platelets, Thousand Per mm3 | 222 (173.8–294.3) | 195 (140.5–262) | <0.001 |
| Creatinine, mg/dL | 0.9 (0.7–1.4) | 1.1 (0.8–2.0) | <0.001 |
| Urea, mg/dL | 38 (25–59) | 53 (35–84) | <0.001 |
| C-reactive Protein, mg/dL | 182.7 (104.1–281.8) | 168.8 (94.1–256.7) | 0.24 |
| D-dimer, μg/mL | 1531 (876.8–4551) | 1692 (964–5485) | 0.39 |
| Lactate Dehydrogenase, U/L | 483 (359.8–611.5) | 519 (390.3–673.3) | 0.04 |
| Comorbidities, n (%) | |||
| Hypertension | 139 (23.5) | 226 (38.2) | <0.001 |
| Diabetes | 92 (15.5) | 148 (25.0) | <0.001 |
| Dialysis | 59 (10.0) | 174 (29.4) | <0.001 |
| Cancer | 8 (1.4) | 43 (7.3) | <0.001 |
| Immunodeficiency | 7 (3.0) | 15 (6.3) | <0.001 |
| Current Smoker | 22 (3.7) | 40 (6.8) | <0.001 |
| Obesity | 89 (15.3) | 81 (14.0) | <0.001 |